RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..8 of 8 - per page
Order by
Rx and /or OTC dermatology products
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Oral, Topical or Transdermal products in any therapeutical area
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Rx and/or OTC Products for Gastroenterology Market
Seeking new technologies and/or existing products More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Seeking innovative oncology, immunology or orphan disease focused prescription based hospital products required for the Portuguese market.
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases. More
Seeking to in-license late stage prescription products into the Nordic region
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Prescription bound chemical substances (NCEs) OR new value added prescription products to in-license for the Nordic market
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark. More
Displaying 1..8 of 8 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Apotex Inc.: PharmaVitae Profile
Dec 2010 - 37 pages - $5,700
H. Lundbeck A/S: PharmaVitae Profile
Dec 2010 - 58 pages - $5,700
Teva Pharmaceutical Industries Ltd: PharmaVitae Profile
Mar 2009 - 59 pages - $5,700
Baxter International Inc.: PharmaVitae Profile
May 2011 - 79 pages - $3,800
Menarini: PharmaVitae Profile
Jun 2010 - 48 pages - $5,700
Biogen Idec Inc.: PharmaVitae Report
Jun 2011 - 66 pages - $5,700
Les Laboratoires Servier: PharmaVitae Profile
Nov 2010 - 76 pages - $5,700
Mylan Inc.: PharmaVitae Profile
Dec 2010 - 55 pages - $5,700
Eisai Co. Ltd: PharmaVitae Profile
Jun 2010 - 68 pages - $5,700
Teva Pharma. Industries Ltd: PharmaVitae Profile
Dec 2010 - 57 pages - $5,700
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us